Market Cap 40.77M
Revenue (ttm) 160,000.00
Net Income (ttm) -13.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -8,362.50%
Debt to Equity Ratio 0.00
Volume 400
Avg Vol 1,326
Day's Range N/A - N/A
Shares Out 3.98M
Stochastic %K 53%
Beta 0.19
Analysts Hold
Price Target $12.00

Company Profile

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pe...

Industry: Biotechnology
Sector: Healthcare
Phone: 248 452 9866
Address:
2125 Butterfield Drive, Suite 100, Troy, United States
trprofit
trprofit Apr. 5 at 5:30 PM
$ZIVO Has anyone heard anything from the company?
0 · Reply
nick275
nick275 Apr. 5 at 12:42 AM
$ZIVO contacted by a longtime investor - another Nick- who made a good case for Zivo delisting. The volume has been close to nonexistent and little benefit to paying for SEC filing requirements. He was more optimistic than me but went through how AG1 has been successful in the algae supplement space and worth many times the market cap of Zivo. I guess we’ll see what the month of April brings.
0 · Reply
ProfessorDman1
ProfessorDman1 Mar. 31 at 8:16 PM
$APVO $ELAB $JAGU $LNKS $ZIVO ( your bids won’t get filled you gotta slap 👋 her ) don’t chase thou when its into double digits APVO
0 · Reply
ProfessorDman1
ProfessorDman1 Mar. 31 at 7:59 PM
$ZIVO nice 😊 $APVO AH runner we could see $10+ $JAGU $LNKS watching $ELAB 200%+ run
1 · Reply
AmigoMike
AmigoMike Mar. 30 at 2:26 PM
$ZIVO 8k filed this morning. Looks like they are moving quickly on the deregistration filing. And includes an apparently unreleased PR https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177449983
0 · Reply
AmigoMike
AmigoMike Mar. 30 at 12:08 AM
$ZIVO just my opinion but if what Payne sez in the PR comes to fruition in the near future ..... then it doesn't matter to me if the company moves to the pink sheets. Payne tossed out there the words the most every analyst and investor wants to hear ..... CASH FLOW POSITIVE apparently is on the horizon. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177447533
0 · Reply
trprofit
trprofit Mar. 29 at 2:58 PM
$ZIVO Take-private transactions, also known as public-to-private deals or P2Ps, occur when a publicly traded company transitions to private ownership. In this process, the company's shares are delisted from a public stock exchange and ownership is consolidated, often among a small group of investors. Buyers in take-private transactions primarily include one or more private equity firms. Management teams often collaborate with these financial sponsors to execute the buyout, as they typically lack the capital to finance such transactions independently. The transition from public to private involves purchasing all outstanding shares from public shareholders, typically at a premium over the current market price. Once private, the company no longer has to meet the extensive regulatory and disclosure requirements imposed on public entities, freeing it to operate with fewer constraints.
1 · Reply
trprofit
trprofit Mar. 28 at 12:40 AM
$ZIVO This sucks! "We intend to deregister the Company’s securities with the Securities and Exchange Commission and cease public reporting"
4 · Reply
nick275
nick275 Mar. 27 at 3:39 PM
$ZIVO looks like insiders driving down the price. Expect buys from the board soon at lower prices diluting other shareholders.
0 · Reply
nick275
nick275 Mar. 23 at 2:34 PM
$ZIVO several employees have left ZIVO recently and they are operating with a skeleton crew. The person responsible for the operations in Peru is now with another algae company.
1 · Reply
Latest News on ZIVO
No data available.
trprofit
trprofit Apr. 5 at 5:30 PM
$ZIVO Has anyone heard anything from the company?
0 · Reply
nick275
nick275 Apr. 5 at 12:42 AM
$ZIVO contacted by a longtime investor - another Nick- who made a good case for Zivo delisting. The volume has been close to nonexistent and little benefit to paying for SEC filing requirements. He was more optimistic than me but went through how AG1 has been successful in the algae supplement space and worth many times the market cap of Zivo. I guess we’ll see what the month of April brings.
0 · Reply
ProfessorDman1
ProfessorDman1 Mar. 31 at 8:16 PM
$APVO $ELAB $JAGU $LNKS $ZIVO ( your bids won’t get filled you gotta slap 👋 her ) don’t chase thou when its into double digits APVO
0 · Reply
ProfessorDman1
ProfessorDman1 Mar. 31 at 7:59 PM
$ZIVO nice 😊 $APVO AH runner we could see $10+ $JAGU $LNKS watching $ELAB 200%+ run
1 · Reply
AmigoMike
AmigoMike Mar. 30 at 2:26 PM
$ZIVO 8k filed this morning. Looks like they are moving quickly on the deregistration filing. And includes an apparently unreleased PR https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177449983
0 · Reply
AmigoMike
AmigoMike Mar. 30 at 12:08 AM
$ZIVO just my opinion but if what Payne sez in the PR comes to fruition in the near future ..... then it doesn't matter to me if the company moves to the pink sheets. Payne tossed out there the words the most every analyst and investor wants to hear ..... CASH FLOW POSITIVE apparently is on the horizon. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177447533
0 · Reply
trprofit
trprofit Mar. 29 at 2:58 PM
$ZIVO Take-private transactions, also known as public-to-private deals or P2Ps, occur when a publicly traded company transitions to private ownership. In this process, the company's shares are delisted from a public stock exchange and ownership is consolidated, often among a small group of investors. Buyers in take-private transactions primarily include one or more private equity firms. Management teams often collaborate with these financial sponsors to execute the buyout, as they typically lack the capital to finance such transactions independently. The transition from public to private involves purchasing all outstanding shares from public shareholders, typically at a premium over the current market price. Once private, the company no longer has to meet the extensive regulatory and disclosure requirements imposed on public entities, freeing it to operate with fewer constraints.
1 · Reply
trprofit
trprofit Mar. 28 at 12:40 AM
$ZIVO This sucks! "We intend to deregister the Company’s securities with the Securities and Exchange Commission and cease public reporting"
4 · Reply
nick275
nick275 Mar. 27 at 3:39 PM
$ZIVO looks like insiders driving down the price. Expect buys from the board soon at lower prices diluting other shareholders.
0 · Reply
nick275
nick275 Mar. 23 at 2:34 PM
$ZIVO several employees have left ZIVO recently and they are operating with a skeleton crew. The person responsible for the operations in Peru is now with another algae company.
1 · Reply
trprofit
trprofit Mar. 18 at 2:46 PM
$ZIVO Man.....Merck is Buying and Buying! If only, eh?
0 · Reply
trprofit
trprofit Mar. 9 at 9:02 PM
$ZIVO Makes you wonder...IF the product is GOOD........ what the hell does ZIVO have to do in order to get a licensing deal or a buyout???
1 · Reply
nick275
nick275 Mar. 2 at 4:25 AM
$ZIVO Mark Strome continues to accumulate. Definitely the most sophisticated investor of those owning more than 5% and hopefully they add him to the BoD.
0 · Reply
trprofit
trprofit Feb. 23 at 10:53 PM
$ZIVO "Signed deal during the first quarter" Could they have meant THIS year?
2 · Reply
nick275
nick275 Feb. 19 at 3:54 PM
$ZIVO I look at my portfolio YTD, 1 year, and 5 year full of green and then there is ZIVO.
0 · Reply
trprofit
trprofit Feb. 17 at 5:08 PM
$ZIVO Staying alive...staying alive
1 · Reply
nick275
nick275 Feb. 17 at 2:30 PM
$ZIVO based on recent filings, it appears the top six beneficial holders collectively control almost 70% of outstanding shares • Laith Yaldoo — 560,272 • Christopher Maggiore — 511,382 • Mark Strome — 476,854 • Keith Marchiando — 431,056 • John Payne — 311,807 • Alison Cornell — 271,471 That level of concentration means a very small group effectively controls the company. What prevents insiders with this much ownership from taking the company private at a depressed valuation? This is why I hesitate to buy.
1 · Reply
nick275
nick275 Feb. 10 at 12:57 PM
$ZIVO It appears 3,174,000 warrants were issued under ZIVOW. These are trading at close to $0 and expire worthless the end of April. I have to believe the deliberate withholding of information from the public by ZIVO insiders is tied to the warrants expiring. Warrants issued to Armistice expired worthless last year.
0 · Reply
nick275
nick275 Feb. 10 at 3:05 AM
$ZIVO I assume no news until ZIVOW warrants expire worthless the end of April. Curious who still holds these. Guessing the board got rid of what they received. These were trading at over $1.50 with decent volume the end of 2024.
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jan. 28 at 11:10 PM
$ZIVO CEO purchased 11,709 shares at $8.54 for a total of $99,995. PAYNE JOHN BERNARD now owns 19,618 shares. https://ceo-buys.com
0 · Reply
nick275
nick275 Jan. 22 at 12:35 PM
$ZIVO CEO John Payne at Mar a Lago. That silly party with people dressed as dogs at Mar a Lago was hosted by Humane Society led by $ZIVO CEO John Payne. Hopefully he has the President’s attention. https://www.ibtimes.co.uk/trumps-latest-mar-lago-party-features-let-them-eat-cake-theme-dog-masked-rococo-dancers-1771182
1 · Reply
trprofit
trprofit Jan. 17 at 4:53 PM
$ZIVO So did anyone else note any change? Zivo Bioscience, Inc. https://www.zivobioscience.com 4 days ago (Jan 13) — A US-based R&D firm, is dedicated to the study, development and commercialization of natural nutritional compounds and bioactive molecules. Copyright 2026 on website
2 · Reply